The University of Chicago Header Logo

Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.

Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma. Otolaryngol Clin North Am. 2017 Dec; 50(6):1111-1119.

View in: PubMed